How to Buy Creative Medical Technology Holdings Stock
Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc. , a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments.
Creative Medical Technology Holdings stock last closed at $2.02, up 3.59% from the previous day, and has decreased 53.93% in one year. It has overperformed other stocks in the Biotechnology industry by 0.23 percentage points. Creative Medical Technology Holdings stock is currently +19.53% from its 52-week low of $1.69, and -70.72% from its 52-week high of $6.90.
As of Apr 29, 2025, there are 1.75M CELZ shares outstanding. The market capitalization of CELZ is $3.53M. In the past 24 hours, 25,292 CELZ shares were traded.
How to Buy Creative Medical Technology Holdings Stock
Wondering how to invest in Creative Medical Technology Holdings stock? Here's how.
Decide where to buy Creative Medical Technology Holdings stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Creative Medical Technology Holdings stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Fund your brokerage account: Choose your method of payment and add your details.
Analyze Creative Medical Technology Holdings stock: The Creative Medical Technology Holdings ticker symbol is CELZ. Is Creative Medical Technology Holdings stock a good investment? Should you buy shares of CELZ? How do CELZ's underlying business fundamentals look? Do top analysts think Creative Medical Technology Holdings is a good buy? Why has CELZ's stock price moved recently? (Hint: Our stock research tools can help you decide if CELZ is a good stock to buy).
Make your CELZ trade: Decide if you will purchase CELZ shares at the current market price or use a limit order to purchase CELZ stock at a specific price.
Get updates on your investment in CELZ: Create a watchlist to keep tabs on your new investment in Creative Medical Technology Holdings stock.
Step 1: Decide where to buy Creative Medical Technology Holdings stock
You will need a brokerage account in order to access the NASDAQ market and buy CELZ stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Tech to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal information so you are able to buy CELZ today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Creative Medical Technology Holdings stock
After you have chosen the best place to buy Creative Medical Technology Holdings stock, it's very important to evaluate their stock before you buy, so you actually comprehend the risk and upside.
Creative Medical Technology Holdings Numbers
CELZ Price
$2.02
1w %
0%
1y %
-53.93%
5y %
-94.06%
P/E
-0.54x
P/B
0.56x
P/S
288.57x
PEG
N/A
Revenue
$11.00k
Earnings
-$5.49M
Fore. Rev. Growth
1,354.24%
Fore. Earn. Growth
N/A
Market Cap
$3.53M
Next Earnings
May 8, 2025
Next Dividend
N/A
Creative Medical Technology Holdings Due Diligence Checks
WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
Last year, CELZ revenue was $11.00k. During the past 5 year, CELZ's revenue has gone up by -41.85% per year. This was slower than the Biotechnology industry average of 45.47%.
No, Creative Medical Technology Holdings doesn't provide an income stream by paying out dividends.
CELZ Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your CELZ trade
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at an exact dollar amount limit, use a limit order.
Press the Open button and your broker will execute your order.
If you want more help investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Creative Medical Technology Holdings share?
As of Apr 29, 2025, it costs $2.02 to buy one share of Creative Medical Technology Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.495 shares of CELZ.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.